retatrutide developer eli lilly New drug may be strongest GLP-1 yet Lilly's new diabetes drug doubled
Description
Standard titration protocols are used
However, NHS availability has been limited due to supply constraints and commissioning decisions, with many areas implementing waiting lists or restricting access to specialist weight management services
Nordstrand, T
1 Irregular heartbeats Across Phase 2 and Phase 3 trials, irregular heartbeats were reported in 2 to 11% of people on retatrutide, compared with around 2% on placebo
Several factors influence how quickly you may lose weight while taking tirzepatide
Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency
